Dirk Eulberg - Publications

CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 21, 2022

The prospect of tumor microenvironment-modulating therapeutical strategies.

Journal: Frontiers in oncology

Published: October 14, 2022

Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects.

Journal: Journal for immunotherapy of cancer

Published: September 07, 2021

CCL2/MCP-1 and CXCL12/SDF-1 blockade by L-aptamers improve pancreatic islet engraftment and survival in mouse.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: March 26, 2019

Intervention of Inflammatory Monocyte Activity Limits Dermal Fibrosis.

Journal: The Journal of investigative dermatology

Published: January 28, 2019

The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers.

Journal: Cellular and molecular gastroenterology and hepatology

Published: July 31, 2018

CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism.

Journal: Kidney international

Published: January 08, 2018

Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition.

Journal: Oncotarget

Published: July 08, 2017

Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.

Journal: The American journal of pathology

Published: January 05, 2017

Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade.

Journal: Cancer immunology research

Published: November 01, 2016

Reprint of "Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis".

Journal: Clinical immunology (Orlando, Fla.)

Published: May 18, 2016

Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis.

Journal: Clinical immunology (Orlando, Fla.)

Published: May 18, 2016